(0.27%) 5 145.25 points
(0.28%) 38 547 points
(0.38%) 17 913 points
(-0.82%) $83.16
(1.30%) $1.948
(-0.12%) $2 344.50
(1.20%) $27.58
(0.62%) $927.80
(-0.26%) $0.932
(-0.21%) $11.00
(-0.37%) $0.797
(0.87%) $92.68
-1.72% INR 534.70
Live Chart Being Loaded With Signals
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally...
Stats | |
---|---|
Tagesvolumen | 115 798 |
Durchschnittsvolumen | 941 192 |
Marktkapitalisierung | 52.29B |
EPS | INR0 ( 2024-02-12 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-05-23 |
Last Dividend | INR1.100 ( 2022-09-19 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -10 694 |
ATR14 | INR0.381 (0.07%) |
Volumen Korrelation
Shilpa Medicare Limited Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Shilpa Medicare Limited Korrelation - Währung/Rohstoff
Shilpa Medicare Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR10.50B |
Bruttogewinn: | INR6.34B (60.39 %) |
EPS: | INR-3.74 |
FY | 2022 |
Umsatz: | INR10.50B |
Bruttogewinn: | INR6.34B (60.39 %) |
EPS: | INR-3.74 |
FY | 2022 |
Umsatz: | INR11.40B |
Bruttogewinn: | INR7.56B (66.31 %) |
EPS: | INR7.26 |
FY | 2021 |
Umsatz: | INR9.00B |
Bruttogewinn: | INR6.29B (69.92 %) |
EPS: | INR18.13 |
Financial Reports:
No articles found.
Shilpa Medicare Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR1.100 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.233 | 2010-09-16 |
Last Dividend | INR1.100 | 2022-09-19 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | INR8.48 | -- |
Avg. Dividend % Per Year | 0.10% | -- |
Score | 0.67 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0.700 | 0.15% |
2019 | INR1.000 | 0.26% |
2020 | INR1.100 | 0.39% |
2021 | INR1.100 | 0.25% |
2022 | INR1.100 | 0.19% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TOUCHWOOD.NS | Dividend Junior | 2023-09-22 | Annually | 6 | 0.15% | |
PGIL.NS | Dividend Junior | 2023-09-01 | Annually | 17 | 1.08% | |
JINDALSAW.NS | Dividend Junior | 2023-06-13 | Annually | 22 | 1.62% | |
DEEPAKNTR.NS | Dividend Junior | 2023-07-27 | Annually | 14 | 0.25% | |
SKMEGGPROD.NS | Dividend Junior | 2023-08-30 | Sporadic | 21 | 0.95% | |
MGEL.NS | Dividend Junior | 2023-08-08 | Annually | 5 | 0.59% | |
HARSHA.NS | Dividend Junior | 2023-09-20 | Insufficient data to determine frequency | 2 | 0.09% | |
BDL.NS | Dividend Junior | 2023-09-20 | Semi-Annually | 7 | 1.17% | |
PTC.NS | Dividend Knight | 2023-09-20 | Annually | 21 | 6.06% | |
KDDL.NS | Dividend Junior | 2023-09-22 | Annually | 8 | 0.29% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.000597 | 1.500 | -0.0119 | -0.0179 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.000377 | 1.500 | -1.115 | -1.673 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.259 | 1.000 | -0.645 | -0.645 | [3 - 30] |
operatingCashFlowPerShareTTM | 24.64 | 2.00 | 1.787 | 3.57 | [0 - 30] |
freeCashFlowPerShareTTM | 24.64 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.644 | 1.000 | 2.60 | 2.60 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0957 | 1.000 | -0.0864 | -0.0864 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -0.346 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -7 041.09 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.000377 | 2.50 | -0.717 | -1.673 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 24.64 | 2.00 | 1.787 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 24.64 | 2.00 | 1.787 | 3.57 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -639.65 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.190 | 1.000 | 7.74 | 0 | [0.1 - 0.5] |
Total Score | -0.690 |
Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.